| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/JAC/44.3.397 |
| P698 | PubMed publication ID | 10511410 |
| P50 | author | Guillermo Quindós Andrés | Q43182008 |
| P2093 | author name string | Y Miranda | |
| A J Carrillo-Muñoz | |||
| O del Valle | |||
| C Tur | |||
| P A Cossum | |||
| T L Wallace | |||
| M T Ruesga | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nystatin | Q251005 |
| fluconazole | Q411478 | ||
| amphotericin B | Q412223 | ||
| P304 | page(s) | 397-401 | |
| P577 | publication date | 1999-09-01 | |
| P1433 | published in | Journal of Antimicrobial Chemotherapy | Q6294770 |
| P1476 | title | In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole | |
| P478 | volume | 44 |
| Q33859133 | Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases |
| Q37450019 | Candida parapsilosis and Candida guillermondii: emerging pathogens in nail candidiasis |
| Q34229980 | Comparative drug disposition, urinary pharmacokinetics, and renal effects of multilamellar liposomal nystatin and amphotericin B deoxycholate in rabbits |
| Q44645307 | Comparison of LNS-AmB, a novel low-dose formulation of amphotericin B with lipid nano-sphere (LNS®), with commercial lipid-based formulations |
| Q42276006 | Development of an antifungal denture adhesive film for oral candidiasis utilizing hot melt extrusion technology |
| Q33983112 | Differential antifungal activity of isomeric forms of nystatin |
| Q46868862 | Epidemiology and antifungal susceptibilities of yeasts causing vulvovaginitis in a teaching hospital |
| Q36973628 | Fluconazole resistant opportunistic oro-pharyngeal Candida and non-Candida yeast-like isolates from HIV infected patients attending ARV clinics in Lagos, Nigeria. |
| Q26740363 | Fungal diseases: could nanostructured drug delivery systems be a novel paradigm for therapy? |
| Q41743814 | In vitro activities of amphotericin B deoxycholate and liposomal amphotericin B against 604 clinical yeast isolates |
| Q39650951 | In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates |
| Q42727587 | In vitro activities of new triazole antifungal agents, posaconazole and voriconazole, against oral Candida isolates from patients suffering from denture stomatitis. |
| Q34452652 | In vitro activity of nystatin compared with those of liposomal nystatin, amphotericin B, and fluconazole against clinical Candida isolates |
| Q41989208 | Investigation on processing variables for the preparation of fluconazole-loaded ethyl cellulose microspheres by modified multiple emulsion technique |
| Q46250284 | Liposomal and Deoxycholate Amphotericin B Formulations: Effectiveness against Biofilm Infections of Candida spp. |
| Q37625418 | Liposomal nystatin in patients with invasive aspergillosis refractory to or intolerant of amphotericin B. |
| Q73810463 | Literature alerts |
| Q46658567 | Microbiota-Gut-Brain Axis: Yeast Species Isolated from Stool Samples of Children with Suspected or Diagnosed Autism Spectrum Disorders and In Vitro Susceptibility Against Nystatin and Fluconazole |
| Q43932444 | New nystatin polymeric complexes and their in vitro antifungal evaluation in a model study with Fusarium oxysporum. |
| Q35116244 | Newer antifungal therapy for emerging fungal pathogens |
| Q32060460 | Pharmacology of itraconazole |
| Q39176593 | Preparation and evaluation of antimicrobial activity of nanosystems for the control of oral pathogens Streptococcus mutans and Candida albicans |
| Q37377752 | Recent approaches to antifungal therapy for invasive mycoses. |
| Q40163020 | Solubilization Behavior of Polyene Antibiotics in Nanomicellar System: Insights from Molecular Dynamics Simulation of the Amphotericin B and Nystatin Interactions with Polysorbate 80. |
| Q34122696 | Uptake of Aspergillus fumigatus Conidia by phagocytic and nonphagocytic cells in vitro: quantitation using strains expressing green fluorescent protein |
Search more.